Computational Pharmacogenomic Screen Identifies Drugs That Potentiate the Anti-Breast Cancer Activity of Statins

Scientists developed an integrative pharmacogenomics pipeline to identify compounds similar to dipyridamole at the level of drug structure, cell sensitivity, and molecular perturbation.